Medical Science Storytelling

GENMARK DIAGNOSTICS

SHOWCASE

GENMARK AND SYNDROMIC MESSAGING

As the world faced a public health emergency with skyrocketing COVID-19 infections starting in 2020, the diagnostics industry received more mainstream attention than ever before. News about the need for, and importance of, diagnostic solutions headlined news reports daily.

Diagnostics play a critical role in successfully navigating the infectious diseases landscape and managing infections that are even more common and more deadly, such as sepsis. GenMark Diagnostics (GenMark) recognized the need to raise awareness of its diagnostics solutions and engaged PCI to support the launch of its Respiratory Pathogen Panel 2 (RP2), a syndromic test that provides rapid results for infections with similar symptoms such as fever, cough and body aches, including COVID-19, flu, bronchitis and the common cold.

TAKING ACTION
PCI took a phased approach to media relations outreach to promote the launch of RP2, first conducting outreach when GenMark submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) and then again when GenMark received EUA for RP2. During the first phase of outreach, GenMark was more focused on trade and investor publications while during the second phase they wanted to achieve more regional and national coverage.

TAKING ACTION

PCI took a phased approach to media relations outreach to promote the launch of RP2, first conducting outreach when GenMark submitted its application for Emergency Use Authorization (EUA) to the U.S. Food and Drug Administration (FDA) and then again when GenMark received EUA for RP2. During the first phase of outreach, GenMark was more focused on trade and investor publications while during the second phase they wanted to achieve more regional and national coverage.

RESULTS
Our team achieved impressive results based on the goals for each phase of outreach culminating in mentions of GenMark on NBC Nightly News and TODAY and inclusion of syndromic messaging.

PHASE ONE
14 Media Placements 360Cx /GenomeWeb/CNBC/COWEN
Inclusion of key syndromic messaging reaching all relevant stakeholder audiences: clinicians, C-Suite, laboratory professionals and investors

PHASE TWO
252 placements reaching an estimated audience of more than 313 million TODAY/NBC Nightly News/San Diego Union-Tribune /Infectious Diseases Special Edition/GenomeWeb/360Dx
99% of placements mentioned GenMark
93% of placements included syndromic messaging
96% of placements included clinical value/benefit messaging

GenMark and Syndromic Messaging Media Placements


Our Sectors	Our Expertise	Contact
Healthcare Organizations	Community Engagement and Mobilization	312.558.1770
Associations	Crisis Communications and Issues	lets_talk@PCIPR.com
Nonprofits	Digital Strategy and Execution
Civic and Park Districts	Integrated Marketing and Communications	Location
Destinations and Culture	Media Relations	Public Communications Inc.
Wildlife & Conservation Organizations	Spokesperson Training	161 N. Clark Street Suite 2050
	On-the-Ground and Virtual Event Support	Chicago, Illinois 60601
	Public Policy
	Reputation Management and Awareness
Privacy Policy \| Sitemap	Strategic Planning
	Visual Communications & Design	© 2024 Public Communications Inc.

Medical Science Storytelling

GENMARK DIAGNOSTICS

SHOWCASE

GENMARK AND SYNDROMIC MESSAGING

KEEP IN TOUCH